The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index; none of the 82 sources its claims cite is checked for support yet.
Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease
Open accessOverview
CoChat Summary
TL;DR
In human hippocampal tissue, GFAP isoform transcripts are differentially abundant and most increase with Alzheimer’s disease progression, while GFAPd and GFAP+1 define distinct astrocyte populations. GFAP+1 cells are a non-reactive astrocyte subset whose numbers rise with amyloid/Braak stage and can be induced by Aβ1-42 in vitro.
Key findings
- Ten GFAP transcripts were detected. With GFAPa set at 100% in amyloid O donors, median relative levels were GFAPd 1.5%, GFAPk 1.1%, GFAPz 0.21%, GFAPD135 0.24%, GFAPb 0.00120%, GFAPDEx6 0.009%, GFAPDEx7 0.006%, and GFAPD164 0.00017%; GFAPDEx6 was detected in 56/75 samples and GFAPD164 in 49/75.
- Most GFAP isoform transcripts increased with AD progression: GFAPa rose 1.3-fold in amyloid A, 2.1-fold in amyloid B, and 2.5-fold in amyloid C versus amyloid O, and increased about 2-fold at Braak 1–3 and about 3-fold at Braak 4–6. GFAPb decreased at Braak stages 3 and 4, with an 8-fold reduction at Braak 3 versus Braak 0 (0.00015% vs. 0.00120%).
- GFAPd immunostaining was prominent in subgranular zone, hilus, CA4, and stratum lacunosum-moleculare, co-localized with GFAPc-term/GFAPa, and was increased in reactive astrocytes near plaques in CA1–3 and subiculum. GFAPk protein could not be detected.
- GFAP+1 cells/cm² ranged from 4 to 82 and correlated with amyloid stage (Rs = 0.58, p < 0.001) and Braak stage (Rs = 0.59, p < 0.001), as well as plaque number density (Rs = 0.62, p < 0.001) and plaque coverage (Rs = 0.47, p < 0.001). In amyloid O–A donors, age added 0.23 GFAP+1 cells/cm² per year (Rs = 0.53, p = 0.017), and females had more GFAP+1 cells/cm² than males (32.4 ± 0.2 vs. 22.0 ± 0.2, p = 0.007). Aβ1-42 oligomers/fibrils induced GFAP+1-positive cells in U343 astrocytoma cultures.
Methods
- Post-mortem human hippocampal tissue was obtained from the Netherlands Brain Bank: 75 donors ranked by amyloid score (O, A, B, C) and Braak staged for tau, plus 10 donors without an NBB amyloid score but with tau scoring. RNA with RIN < 5.0 was excluded; qPCR for GFAP isoforms used a normalization factor based on 10 reference genes.
- Immunofluorescence was performed on lightly fixed cryosections with isoform-specific antibodies; Western blotting used recombinant GFAP isoforms expressed in SW-13cl.2 cells. Cell culture experiments used U343 astrocytoma and SW-13cl.2 cells, including Aβ1-42 oligomer/fibril treatment and MTT assays.
- GFAP+1 cells and amyloid plaques were quantified in hippocampal sections, and analyses used non-parametric methods (Kruskal-Wallis, Spearman rank correlation, Mann-Whitney U), with p < 0.05 considered significant.
Limitations
- Stated in the paper: the qPCR isoform profile is based on plasmid calibration curves and does not correct for potential different cDNA synthesis efficiencies among transcripts; GFAP+1-encoding transcripts are very low, variable, and not detectable in all samples, and it is unknown whether they originate only from GFAP+1 cells or from all astrocytes at very low abundance.
- Stated in the paper: overexpression constructs express the N-terminus of GFAPa, but the exact in vivo N-terminal head domain of GFAPD164 and GFAPDEx6 has not been determined, so the constructs may not represent endogenous GFAP+1 isoforms and filament-formation results may differ. The paper also notes it could not determine which transcript underlies GFAP+1 protein in vivo, and laser dissection of GFAP+1 cells did not yield a consistent transcript profile.
- Evident from the text: this is a human post-mortem correlational study; amyloid O donors were significantly younger than amyloid B and C donors, and age and sex effects on GFAP+1 cell numbers were observed, so AD-related increases may be partly confounded by age/sex. The paper states that whether the increase in GFAP+1 cells has consequences for the disease process cannot be derived from the data.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 45 Not checked · 210 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Transcript levels of most isoforms increased with AD progression.”
§ Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease > Abstract
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Many GFAPd cells were found in the stratum lacunosum-moleculare of CA1-3 and the alveus.”
§ Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease > 3.5. GFAP isoform immunostaining
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“GFAPd-positive cells also stained for GFAPa.”
- Also stated in: § 3.5. GFAP isoform immunostaining · plain
“Double staining showed co-localization of GFAPd-positive astrocytes with GFAPc-term (Fig. 3E and F).”
§ Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease > Abstract
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 3.5. GFAP isoform immunostaining · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition, reactive astrocytes were found that surrounded small areas of Ab staining with a non-filamentous pattern (Fig. 3C).”
§ Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease > 3.5. GFAP isoform immunostaining
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Transcript levels of genes encoding for other intermediate filament genes vimentin, nestin, synemin-a, and synemin-b were also increased along the same pattern as that of GFAP (Table 1).”
§ Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease > 3.3. GFAP isoform transcript levels are increased in human AD
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
125 more claims
Create a free account to see all 255 claims and to verify the 75 references still open.
- It may state two separate claims as one. 99
- The quote only partly states this claim. 4
- Probably not a substantial claim. 44
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease > 3.3. GFAP isoform transcript levels are increased in human AD
“Compared to amyloid O, GFAPa levels significantly increased 1.3-fold in amyloid A, 2.1-fold in amyloid B, and 2.5-fold in amyloid C samples (Fig. 1B).”
§ Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease > 3.5. GFAP isoform immunostaining
“GFAPa 1.00 (0.82e1.67) 1.48 (1.12e1.74)1.88* (1.40e2.74)2.58*** (1.70e3.85)”
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease > 4.2. GFAP isoform transcript levels increase in human AD
“In human cDNA samples from AD donors all GFAP isoforms were significantly increased, reaching a 1.5-to 3.2-fold increase at endstage AD (amyloid C/Braak 6).”
§ Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease > 3.5. GFAP isoform immunostaining
“GFAPD164 b 1.00 (0.06e1.50) 0.74 (0.43e1.74) 1.68 (0.59e2.90) 0.94 (0.06e3.57)GFAPDEx6 b 1.00 (0.03e1.78) 1.17 (0.91e1.36) 1.54 (0.91e3.93) 1.29 (0.23e2.38)GFAPDEx7 1.00 (0.50e1.78) 1.39 (0.99e1.87) 0.99 (0.52e1.84) 2.26 (1.15e3.28)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease > Disclosure statement
“7 different isoforms are expressed in all samples”
§ Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease > 3.2. GFAP isoform transcript level profile in human hippocampus
“GFAPa, GFAPb, GFAPg, GFAPd, GFAPk, GFAPz, GFAPDEx7, and GFAPD135 transcript levels were determined in all 75 samples.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease > 3.3. GFAP isoform transcript levels are increased in human AD
“GFAPb significantly decreased in Braak stages 3 and 4, and recovered thereafter (Table 2).”
§ Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease > 3.5. GFAP isoform immunostaining
“GFAPb 1.00 (0.78e1.65) 0.83 (0.73e2.28) 0.39* (0.25e0.85) 0.33*** (0.26e0.69) 1.41 (0.88e1.80)”
Citations
Cites
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Astrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196
Astrocyte activation and reactive gliosis
Pekny, M., & Nilsson, M. (2005) · Glia · doi:10.1002/glia.20207 · Cited by 1,611
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489
Uniquely Hominid Features of Adult Human Astrocytes
Oberheim, N. A., Takano, T., Han, X., He, W., Lin, J. H. C., Wang, F., Xu, Q., Wyatt, J. D., Pilcher, W., Ojemann, J. G., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4707-08.2009 · Cited by 1,488
RNA integrity and the effect on the real-time qRT-PCR performance
Fleige, S., & Pfaffl, M. W. (2006) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2005.12.003 · Cited by 1,487
Middeldorp, J., & Hol, E. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.01.005 · Cited by 1,080
Self-citationAdult mouse astrocytes degrade amyloid-β in vitro and in situ
Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., Silverstein, S. C., & Husemann, J. (2003) · Nature Medicine · doi:10.1038/nm838 · Cited by 909
Epigenetics in Alternative Pre-mRNA Splicing
Luco, R. F., Allo, M., Schor, I. E., Kornblihtt, A. R., & Misteli, T. (2011) · Cell · doi:10.1016/j.cell.2010.11.056 · Cited by 796
Integrated Brain Circuits: Astrocytic Networks Modulate Neuronal Activity and Behavior
Halassa, M. M., & Haydon, P. G. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135843 · Cited by 763
Protective Role of Reactive Astrocytes in Brain Ischemia
Li, L., Lundkvist, A., Andersson, D., Wilhelmsson, U., Nagai, N., Pardo, A. C., Nodin, C., Ståhlberg, A., Aprico, K., Larsson, K., et al. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600546 · Cited by 505
Wilhelmsson, U., Li, L., Pekna, M., Berthold, C.-H., Blom, S., Eliasson, C., Renner, O., Bushong, E., Ellisman, M., Morgan, T. E., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0820-04.2004 · Cited by 455
Astrocytes in Alzheimer's Disease
Verkhratsky, A., Olabarria, M., Noristani, H. N., Yeh, C.-Y., & Rodriguez, J. J. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.017 · Cited by 455
Carter, S. F., Schöll, M., Almkvist, O., Wall, A., Engler, H., Långström, B., & Nordberg, A. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.087031 · Cited by 442
Astrocyte phenotype in relation to Alzheimer‐type pathology in the ageing brain
Simpson, J. E., Ince, P. G., Lace, G., Forster, G., Shaw, P. J., Matthews, F., Savva, G., Brayne, C., & Wharton, S. B. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.05.015 · Cited by 381
Sequence of Aβ-protein deposition in the human medial temporal lobe
Thal, D. R., Rüb, U., Schultz, C., Sassin, I., Ghebremedhin, E., Del Tredici, K., Braak, E., & Braak, H. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.8.733 · Cited by 370
Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice
Kraft, A. W., Hu, X., Yoon, H., Yan, P., Xiao, Q., Wang, Y., Gil, S. C., Brown, J., Wilhelmsson, U., Restivo, J. L., et al. (2013) · The FASEB Journal · doi:10.1096/fj.12-208660 · Cited by 355
Targeting Astrocytes Ameliorates Neurologic Changes in a Mouse Model of Alzheimer's Disease
Furman, J. L., Sama, D. M., Gant, J. C., Beckett, T. L., Murphy, M. P., Bachstetter, A. D., Van Eldik, L. J., & Norris, C. M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2323-12.2012 · Cited by 313
Kamphuis, W., Mamber, C., Moeton, M., Kooijman, L., Sluijs, J. A., Jansen, A. H. P., Verveer, M., de Groot, L. R., Smith, V. D., Rangarajan, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042823 · Cited by 303
Self-citationAllaman, I., Gavillet, M., Bélanger, M., Laroche, T., Viertl, D., Lashuel, H. A., & Magistretti, P. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5098-09.2010 · Cited by 278
Hu, J., Akama, K. T., Krafft, G. A., Chromy, B. A., & Van Eldik, L. J. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01318-8 · Cited by 262
Immune reactive cells in senile plaques and cognitive decline in Alzheimer’s disease
Vehmas, A. K., Kawas, C. H., Stewart, W. F., & Troncoso, J. C. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00090-8 · Cited by 230
Chakrabarty, P., Ceballos-Diaz, C., Beccard, A., Janus, C., Dickson, D., Golde, T. E., & Das, P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903382 · Cited by 206
Emerging role for the cytoskeleton as an organizer and regulator of translation
Kim, S., & Coulombe, P. A. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2818 · Cited by 198
Reactive glial cells: increased stiffness correlates with increased intermediate filament expression
Lu, Y., Iandiev, I., Hollborn, M., Körber, N., Ulbricht, E., Hirrlinger, P. G., Pannicke, T., Wei, E., Bringmann, A., Wolburg, H., et al. (2011) · The FASEB Journal · doi:10.1096/fj.10-163790 · Cited by 172
Hol, E. M., Roelofs, R. F., Moraal, E., Sonnemans, M. A. F., Sluijs, J. A., Proper, E. A., de Graan, P. N. E., Fischer, D. F., & van Leeuwen, F. W. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001379 · Cited by 165
Self-citationIntermediate filaments regulate astrocyte motility
Lepekhin, E. A., Eliasson, C., Berthold, C., Berezin, V., Bock, E., & Pekny, M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00595.x · Cited by 164
Pihlaja, R., Koistinaho, J., Malm, T., Sikkilä, H., Vainio, S., & Koistinaho, M. (2008) · Glia · doi:10.1002/glia.20599 · Cited by 162
Cytoskeleton and Vesicle Mobility in Astrocytes
Potokar, M., Kreft, M., Li, L., Daniel Andersson, J., Pangršič, T., Chowdhury, H. H., Pekny, M., & Zorec, R. (2007) · Traffic · doi:10.1111/j.1600-0854.2006.00509.x · Cited by 162
Roelofs, R. F., Fischer, D. F., Houtman, S. H., Sluijs, J. A., Van Haren, W., Van Leeuwen, F. W., & Hol, E. M. (2005) · Glia · doi:10.1002/glia.20243 · Cited by 158
Self-citationHigh Susceptibility to Cerebral Ischemia in GFAP-Null Mice
Nawashiro, H., Brenner, M., Fukui, S., Shima, K., & Hallenbeck, J. M. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200007000-00003 · Cited by 149
Apelt, J., Ach, K., & Schliebs, R. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00030-2 · Cited by 140
Sarría, A. J., Lieber, J. G., Nordeen, S. K., & Evans, R. M. (1994) · Journal of Cell Science · doi:10.1242/jcs.107.6.1593 · Cited by 137
Thal, D. R., Schultz, C., Dehghani, F., Yamaguchi, H., Braak, H., & Braak, E. (2000) · Acta Neuropathologica · doi:10.1007/s004010000242 · Cited by 136
Allele-specific nuclear positioning of the monoallelically expressed astrocyte marker GFAP
Takizawa, T., Gudla, P. R., Guo, L., Lockett, S., & Misteli, T. (2008) · Genes & Development · doi:10.1101/gad.1634608 · Cited by 135
Wang, Q., Ishikawa, T., Michiue, T., Zhu, B.-L., Guan, D.-W., & Maeda, H. (2012) · International Journal of Legal Medicine · doi:10.1007/s00414-012-0774-7 · Cited by 132
A star is born: new insights into the mechanism of astrogenesis
Kanski, R., van Strien, M. E., van Tijn, P., & Hol, E. M. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1435-9 · Cited by 132
Self-citationSpatial relationships between astrocytes and classical plaque components
Wisniewski, H. M., & Wegiel, J. (1991) · Neurobiology of Aging · doi:10.1016/0197-4580(91)90091-w · Cited by 124
Astrocytes in Alzheimer's Disease: Emerging Roles in Calcium Dysregulation and Synaptic Plasticity
Vincent, A. J., Gasperini, R., Foa, L. C., & Small, D. H. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101089 · Cited by 121
Van Den Berge, S. A., Middeldorp, J., Zhang, C. E., Curtis, M. A., Leonard, B. W., Mastroeni, D., Voorn, P., Van De Berg, W. D. J., Huitinga, I., & Hol, E. M. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00556.x · Cited by 119
Self-citationAstrocyte, the star avatar: redefined
Seth, P., & Koul, N. (2008) · Journal of Biosciences · doi:10.1007/s12038-008-0060-5 · Cited by 112
Intermediate filaments attenuate stimulation‐dependent mobility of endosomes/lysosomes in astrocytes
Potokar, M., Stenovec, M., Gabrijel, M., Li, L., Kreft, M., Grilc, S., Pekny, M., & Zorec, R. (2010) · Glia · doi:10.1002/glia.21000 · Cited by 111
Jing, R., Wilhelmsson, U., Goodwill, W., Li, L., Pan, Y., Pekny, M., & Skalli, O. (2007) · Journal of Cell Science · doi:10.1242/jcs.03423 · Cited by 110
Durrenberger, P. F., Fernando, F. S., Magliozzi, R., Kashefi, S. N., Bonnert, T. P., Ferrer, I., Seilhean, D., Nait-Oumesmar, B., Schmitt, A., Gebicke-Haerter, P. J., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1027-z · Cited by 107
Feinstein, D. L., Weinmaster, G. A., & Milner, R. J. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490320102 · Cited by 103
Intermediate filaments as signaling platforms
Pallari, H.-M., & Eriksson, J. E. (2006) · Science's STKE · doi:10.1126/stke.3662006pe53 · Cited by 100
Perng, M.-D., Wen, S.-F., Gibbon, T., Middeldorp, J., Sluijs, J., Hol, E. M., & Quinlan, R. A. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-03-0284 · Cited by 98
Self-citationMice lacking GFAP are hypersensitive to traumatic cerebrospinal injury
Nawashiro, H., Messing, A., Azzam, N., & Brenner, M. (1998) · NeuroReport · doi:10.1097/00001756-199806010-00004 · Cited by 98
A β 1-42 Induces Mild Endoplasmic Reticulum Stress in an Aggregation State–Dependent Manner
Chafekar, S. M., Hoozemans, J. J. M., Zwart, R., Baas, F., & Scheper, W. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1797 · Cited by 97
Pihlaja, R., Koistinaho, J., Kauppinen, R., Sandholm, J., Tanila, H., & Koistinaho, M. (2011) · Glia · doi:10.1002/glia.21212 · Cited by 96
Binding and uptake of Aβ1‐42 by primary human astrocytes in vitro
Nielsen, H. M., Veerhuis, R., Holmqvist, B., & Janciauskiene, S. (2009) · Glia · doi:10.1002/glia.20822 · Cited by 96
Nielsen, A. L., Holm, I. E., Johansen, M., Bonven, B., Jørgensen, P., & Jørgensen, A. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112121200 · Cited by 92
MURAMORI, F., KOBAYASHI, K., & NAKAMURA, I. (1998) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1998.tb02706.x · Cited by 85
Enhanced hippocampal neurodegeneration after traumatic or kainate excitotoxicity in GFAP-null mice
Otani, N., Nawashiro, H., Fukui, S., Ooigawa, H., Ohsumi, A., Toyooka, T., Shima, K., Gomi, H., & Brenner, M. (2006) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2005.10.018 · Cited by 83
Kato, S., Gondo, T., Hoshii, Y., Takahashi, M., Yamada, M., & Ishihara, T. (1998) · Pathology International · doi:10.1111/j.1440-1827.1998.tb03915.x · Cited by 73
Datki, Z., Papp, R., Zádori, D., Soós, K., Fülöp, L., Juhász, A., Laskay, G., Hetényi, C., MIHALIK, E., & Zarándi, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.08.007 · Cited by 72
Glial fibrillary acidic protein is necessary for mature astrocytes to react to ?-amyloid
Xu, K., Malouf, A. T., Messing, A., & Silver, J. (1999) · Glia · doi:10.1002/(sici)1098-1136(19990215)25:4<390::aid-glia8>3.0.co;2-7 · Cited by 70
Structural features of the rat GFAP gene and identification of a novel alternative transcript
Condorelli, D. F., Nicoletti, V. G., Barresi, V., Conticello, S. G., Caruso, A., Tendi, E. A., & Stella, A. M. G. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990501)56:3<219::aid-jnr1>3.0.co;2-2 · Cited by 65
Identification and characterization of GFAPκ, a novel glial fibrillary acidic protein isoform
Blechingberg, J., Holm, I. E., Nielsen, K. B., Jensen, T. H., Jørgensen, A. L., & Nielsen, A. L. (2007) · Glia · doi:10.1002/glia.20475 · Cited by 65
Vimentin participates in microglia activation and neurotoxicity in cerebral ischemia
Jiang, S. X., Slinn, J., Aylsworth, A., & Hou, S. T. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07823.x · Cited by 60
Intra-organ variation in age-related mutation accumulation in the mouse
Busuttil, R. A., Garcia, A. M., Reddick, R. L., Dollé, M. E. T., Calder, R. B., Nelson, J. F., & Vijg, J. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000876 · Cited by 54
A novel glial fibrillary acidic protein mRNA lacking exon 1
Zelenika, D., Grima, B., Brenner, M., & Pessac, B. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00010-p · Cited by 54
Increased astrocytic ATP release results in enhanced excitability of the hippocampus
Lee, H. U., Yamazaki, Y., Tanaka, K. F., Furuya, K., Sokabe, M., Hida, H., Takao, K., Miyakawa, T., Fujii, S., & Ikenaka, K. (2012) · Glia · doi:10.1002/glia.22427 · Cited by 54
β‐Amyloid peptide induced cytoskeletal reorganization in cultured astrocytes
Salinero, O., Moreno-Flores, M. T., Ceballos, M. L., & Wandosell, F. G. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970115)47:2<216::aid-jnr10>3.3.co;2-1 · Cited by 51
Intermediate filament transcription in astrocytes is repressed by proteasome inhibition
Middeldorp, J., Kamphuis, W., Sluijs, J. A., Achoui, D., Leenaars, C. H. C., Feenstra, M. G. P., van Tijn, P., Fischer, D. F., Berkers, C. R., Ovaa, H., et al. (2009) · The FASEB Journal · doi:10.1096/fj.08-127696 · Cited by 48
Self-citation?-Amyloid peptide induced cytoskeletal reorganization in cultured astrocytes
Salinero, O., Moreno-Flores, M. T., CEBALLOS, M. L. D., & Wandosell, F. G. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970115)47:2<216::aid-jnr10>3.0.co;2-0 · Cited by 40
Measuring genome instability in aging - a mini-review
Li, W., & Vijg, J. (2012) · Gerontology · doi:10.1159/000334368 · Cited by 34
Hanzel, D. K., Trojanowski, J. Q., Johnston, R. F., & Loring, J. F. (1999) · Nature Biotechnology · doi:10.1038/5225 · Cited by 33
Middeldorp, J., van den Berge, S. A., Aronica, E., Speijer, D., & Hol, E. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007663 · Cited by 30
Self-citationEffects of inducible glial fibrillary acidic protein on glioma cell motility and proliferation
Elobeid, A., Bongcam-Rudloff, E., Westermark, B., & Nist�r, M. (2000) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(20000415)60:2<245::aid-jnr14>3.0.co;2-1 · Cited by 28
Yoshida, T., Tomozawa, Y., Arisato, T., Okamoto, Y., Hirano, H., & Nakagawa, M. (2007) · Journal of Human Genetics · doi:10.1007/s10038-007-0124-7 · Cited by 27
Genetic Background Affects Human Glial Fibrillary Acidic Protein Promoter Activity
Bai, X., Saab, A. S., Huang, W., Hoberg, I. K., Kirchhoff, F., & Scheller, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066873 · Cited by 25
GFAPβ mRNA Expression in the Normal Rat Brain and after Neuronal Injury
Condorelli, D. F., Nicoletti, V. G., Dell’Albani, P., Barresi, V., Caruso, A., Conticello, S. G., Belluardo, N., & Stella, A. M. G. (1999) · Neurochemical Research · doi:10.1023/a:1021016828704 · Cited by 22
Boer, K., Middeldorp, J., Spliet, W. G. M., Razavi, F., van Rijen, P. C., Baayen, J. C., Hol, E. M., & Aronica, E. (2010) · Epilepsy Research · doi:10.1016/j.eplepsyres.2010.03.014 · Cited by 16
Self-citation
Cited by
Glial fibrillary acidic protein: From intermediate filament assembly and gliosis to neurobiomarker
Yang, Z., & Wang, K. K. W. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.04.003 · Cited by 1,050
Hol, E. M., & Pekny, M. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.02.004 · Cited by 917
Self-citationAstrocytes: a central element in neurological diseases
Pekny, M., Pekna, M., Messing, A., Steinhäuser, C., Lee, J.-M., Parpura, V., Hol, E. M., Sofroniew, M. V., & Verkhratsky, A. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1513-1 · Cited by 755
Self-citationAutophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications
Uddin, M. S., Stachowiak, A., Mamun, A. A., Tzvetkov, N. T., Takeda, S., Atanasov, A. G., Bergantin, L. B., Abdel-Daim, M. M., & Stankiewicz, A. M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00004 · Cited by 395
Astrocyte Heterogeneity: Impact to Brain Aging and Disease
Matias, I., Morgado, J., & Gomes, F. C. A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00059 · Cited by 387
Metadata
- Authors
- Kamphuis, W., Middeldorp, J., Kooijman, L., Sluijs, J. A., Kooi, E.-J., Moeton, M., Freriks, M., Mizee, M. R., & Hol, E. M.
- Affiliations
- Netherlands Institute for Neuroscience (NL)
- Corresponding author
- Kamphuis, Willem
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2014-03
- Volume
- 35
- Issue
- 3
- Pages
- 492-510
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2039930606
- Cited by
- 269
- References
- 75
- Citations by year
- 2026: 17 · 2025: 21 · 2024: 25 · 2023: 24 · 2022: 35 · 2021: 28 · 2020: 27 · 2019: 13 · 2018: 17 · 2017: 23 · 2016: 10 · 2015: 20 · 2014: 9
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 281 d)
- Locations
- Neurobiology of Aging (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (publishedVersion, other-oa)
- KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (publishedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Internationale Stichting Alzheimer Onderzoek (ISAO 08504)
- NANONET COST (BM1002)
- Netherlands Organization (865.09.003)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Skin and Cellular Biology Research
- Keywords
- Alzheimer's disease, glial fibrillary acidic protein, astrocyte activation, amyloid plaques, reactive astrocytes, intermediate filaments, hippocampus, disease progression, mRNA levels
- MeSH terms
- Alzheimer Disease, Astrocytes, Cells, Cultured, Glial Fibrillary Acidic Protein, Hippocampus, Humans, Severity of Illness Index, Transcription, Genetic, Up-Regulation, Gene Expression, Disease Progression, Protein Isoforms, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.